Ionis Pharmaceuticals Files 2025 Proxy Statement
Ticker: IONS · Form: DEF 14A · Filed: Apr 25, 2025 · CIK: 874015
Sentiment: neutral
Topics: proxy-statement, governance, shareholder-meeting
TL;DR
IONIS proxy filed - shareholders vote on exec pay & board at June 5 meeting.
AI Summary
Ionis Pharmaceuticals, Inc. filed its definitive proxy statement (DEF 14A) on April 25, 2025, for its annual meeting on June 5, 2025. The filing details the company's governance and executive compensation practices. Ionis Pharmaceuticals, Inc. is headquartered in Carlsbad, California, and operates in the pharmaceutical preparations industry.
Why It Matters
This filing provides shareholders with crucial information regarding company leadership, voting matters, and executive compensation, enabling informed participation in corporate governance decisions.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing for a public company, providing information to shareholders rather than announcing new material events.
Key Numbers
- 20250425 — Filing Date (The date the definitive proxy statement was filed with the SEC.)
- 20250605 — Meeting Date (The date of the shareholder meeting for which this proxy statement is issued.)
Key Players & Entities
- IONIS PHARMACEUTICALS INC (company) — Registrant
- 2855 GAZELLE COURT, CARLSBAD, CA 92010 (address) — Business and Mail Address
- 7609319200 (phone_number) — Business Phone
- ISIS PHARMACEUTICALS INC (company) — Former Company Name
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is filed by a company to provide shareholders with information they need to vote on matters at an upcoming shareholder meeting, such as the election of directors and executive compensation.
When is the shareholder meeting for Ionis Pharmaceuticals, Inc.?
The shareholder meeting for Ionis Pharmaceuticals, Inc. is scheduled for June 5, 2025.
What is the company's primary business sector?
Ionis Pharmaceuticals, Inc. operates in the Pharmaceutical Preparations sector, with the Standard Industrial Classification code 2834.
Where is Ionis Pharmaceuticals, Inc. headquartered?
Ionis Pharmaceuticals, Inc. is headquartered in Carlsbad, California, with its business and mail address at 2855 Gazelle Court, Carlsbad, CA 92010.
Has the company's name changed previously?
Yes, the company was formerly known as ISIS PHARMACEUTICALS INC, with a date of name change on March 28, 1993.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 25, 2025 regarding IONIS PHARMACEUTICALS INC (IONS).